Found 37 matching trials
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
PHASE3This is a multicenter, randomized controlled, phase III clinical trial. The...
Location
Sun Yat-sen University Cancer Center
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3The purpose of this study is to compare induction chemotherapy (gemcitabine...
Location
Sun Yat-sen University Cancer Center
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
PHASE3This multicenter, open-label, randomized Phase III trial evaluates intensit...
Location
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
PHASE2The investigators aim to investigate whether incorporating on-treatment EBV...
Location
Sun Yat-sen University Cancer Center
TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
PHASE2The NCCN guidelines recommend induction chemotherapy followed by concurrent...
Location
Sun Yat-sen University Cancer Center
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
PHASE3This is a multicenter, open-label, randomized, controlled, phase III trial....
Location
Sun Yat-sen University Cancer Center
GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China
PHASE2The present study is a randomized, control, phase II study of locally advan...
Location
Department of Radiation Oncology, Xijing Hospital, Fourth Military
Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma
PHASE2This study is to investigate the efficacy and safety of the induction chemo...
Location
Multiple Locations
GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC
PHASE3Through randomized controlled phase III multicenter clinical trials, GP ind...
Location
Cancer Hospital of Guizhou Medical University
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3This randomized controlled trial aims to evaluate the efficacy and safety o...
Location
Multiple Locations